Nitrous Oxide Neuroimaging

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-59
SponsorKeith M Vogt

About this trial

The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose nitrous oxide. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will occur over 2 visits and involves no long-term follow up.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

have none of the specific

Disqualifiers

have a valid email address and valid phone number throughout the study

free from any non-MRI compatible implants

are pregnant or attempting to conceive

body mass index (BMI) > 35

Trial design

Design model

Single group

Treatments tested in this trial

  • Nitrous oxide

    Drug

    After a no-drug control period, subjects will inhale nitrous oxide, administered via a breathing circuit and face mask, until a steady-state target end-tidal expired concentration is reached. During the drug condition, subjects will receive low-dose nitrous oxide (% corresponding to Minimum Alveolar Concentration).

  • Peripheral Nerve Stimulation

    Device

    Experimental acute pain stimulus will be delivered using a nerve stimulator. These painful shocks will be paired with a fixed number of the experimental cues, in a pattern that appears random to participants.

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Nitrous Oxide + PainExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Brain activation to painful stimulation difference: Drug-free condition minus nitrous oxide condition

Event-related blood-oxygen level dependent Magnetic Resonance Imaging (MRI) responses will be determined. Z-scores will be calculated by linear regression of the task timing against the MRI signal time-course (MRI data is in arbitrary units with no maximum or minimum) at each voxel (single data point in brain). Primary outcome will be for the right insula. Z-score of 0 indicates no task-related changes. Z-scores further from zero indicate stronger correlation between functional MRI signal change and the task timing, with positive values indicating increases in functional MRI signal and negative Z-scores indicating decreases. Practically, higher positive Z-scores would indicate increased brain activity and larger negative Z-scores would indicate decreased brain activity.

Time frame
Visit 1: Immediate; average activity, calculated from each task scan
2

Resting-state functional connectivity difference: Drug-free minus nitrous oxide condition

Functional connectivity (FC) will be calculated as the correlation between the time-series of MRI signal (MRI data is in arbitrary units with no maximum or minimum) on a pair-wise basis between every atlas-defined region in the brain. Strength of temporal correlation is reflective of brain regions that are working together, and changes in FC reflect differences in brain state, in this case between the drug-free and nitrous oxide conditions. The reported value will be for FC change between insula and anterior cingulate. T-score of 0 would indicate no condition-related changes in connectivity between the two brain regions. T-scores further from zero indicate stronger connectivity change: positive T-score reflects drug-free \> nitrous oxide; negative T-scores indicate nitrous oxide \> drug-free.

Time frame
Visit 1: Immediate; brain activity captured in data acquired across entire 6-8 minute scan.

Secondary outcomes

1

Explicit memory performance

Recognition memory testing, using the Remember-Know procedure, in which subjects indicate whether they recognize previously experienced experimental items among novel items (not previously in the experiment). This allows calculation of interdependent measures of recollection \& familiarity using the signal detection statistic, d'. d' is calculated as the cumulative Gaussian distribution of false positive responses subtracted from the cumulative Gaussian distribution of correctly identified previously-experienced items. d' is on a (theoretically infinite) scale of standard deviation units, with negative values representing performance worse than chance guessing and positive values representing stand deviations of performance above chance.

Time frame
Visit 2: 24 hours post-learning experiment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Keith M Vogt

Lead sponsor

University of Pittsburgh

Sponsor institution

National Institute of General Medical Sciences (NIGMS)

Collaborator